This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Paris, will open in May (18-19) with connectivity, sustainability and user experience identified as the key trends in 2022 influencing innovation across pharmaceutical packaging and drugdelivery.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. An example is the ability of a patient suffering from venous thrombosis to perform their own injections of heparin – an anticoagulant often packaged in a prefilled syringe.
PCI has “heavily invested” in new drugdelivery tech at its Philadelphia headquarters, laid plans for a 545,000-square-foot expansion in Rockford, Illinois, acquired a new packaging and device assembly plant near Dublin, Ireland, and broken ground on another at its CityNorth Dublin campus.
Bormioli Pharma creates pharmaceutical packaging for drug stability, safety, and sustainability, partnering with global health leaders and says it stands at the forefront of sustainability.
Paris, Ahead of the first Pharmapack Europe to be held in nearly 18-months, Informa has released the results of its global drugdelivery and packaging survey, with the USA once again leading ‘drugdelivery and device innovation’, but lagging behind all major European nations on sustainability.
SMi presents the 4 th Annual Ophthalmic Drugs Conference taking place on the 23 rd -24 th November 2020, in London. Workshop will be on ‘Ophthalmic DrugDelivery Development – Trials and Tribulations’. Ophthalmic Drugs Conference. Hosted by Brian Levy, CEO, Ocunexus Therapeutics. 23 rd -24 th November 2020.
These issues primarily stem from patients and healthcare providers miscalculating or incorrectly administering the drug. Compounded semaglutide products, unlike the US Food and Drug Administration (FDA)-approved ones, can vary widely in strength and packaging, making it easy for mistakes to happen.
CPhI Worldwide will see Gerresheimer showcase its latest developments in primary packaging, drugdelivery systems for newly developed biologics along with medical and diagnostic products.
Sustainability for Injectable Delivery Devices. Primary Packaging Development. Connected DrugDelivery Devices. Hear about new technological advances in the delivery of large volume drugs. Delve into the considerations for material components for the development of primary packaging.
Organizers of the drugdelivery and packaging event have shared an industry report that reveals what is likely to push innovation forward in the future.
Pharmaceutical solid dosage forms are the most popular in the pharmaceutical industry and are one of the most used drugdelivery methods across patient groups. Drug manufacturers have been investing significantly in the R&D of more effective and patient-friendly solid forms.
Robotics, for example, has facilitated the automation of medicine preparation and distribution, controlled drugdelivery systems, and machine-readable coding on medicine packages. Newly emerging technologies have helped in improving the effectiveness and safety of non-sterile commercial dose products.
The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. As part of SAE Media Group’s leading injectable drugdelivery portfolio, this event is not to be missed.
SMi Group’s 14 th Annual Conference and Exhibition: Pre-Filled Syringes and Injectable Drug Devices 2022 – 12 th – 13 th January 2022. Sustainability for Drug Devices Focus Day – 14 th January 2022. The Future of DrugDelivery and Combination Product Device Design. Joel Richard, Chief Development Officer, MedinCell.
” XTALKS WEBINAR: DrugDelivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about the differences and similarities between the US and EU regulatory frameworks for co-packaged combination products.
XTALKS WEBINAR: DrugDelivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about on-body drugdelivery systems and addressing their complex global regulatory requirements.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. Consequently, pharmaceutical and biotech companies are increasingly looking to provide devices that allow patients to self-administer drugs.
The Latest Innovations In Digital Health And On-Body DrugDelivery For The Pharmaceutical Industry. Discover advances in device design and development for large volume delivery via on-body injectors. Explore the key drivers of novel drug products for the development for on-body injectors. Novo Nordisk. And many more!!
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drugdelivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.
The company developing drug product through such an intense process, use to consider container closure system only for packaging of the product. [1] Thereafter, high quality standards were set for packaging and closure of such containers by the regulatory bodies. [2] Our Social Media Platform. Web: [link]. LinkedIn: [link].
The US Food and Drug Administration (FDA) also has concerns about the toxic effects of EtO and thus is continuing to encourage new ways to sterilize medical devices and strategies to mitigate the emission levels of EtO while achieving adequate sterilization.
They offer several advantages over traditional drugdelivery systems ( such as vials and syringes ), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination.
The Mayne Pharma Academy offers employees ongoing learning opportunities which include certificate programs and courses covering technical, scientific and professional training to help establish the company’s leadership in drug-delivery science. Employee Compensation and Rewards.
Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery. As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. reaching £915 billion by 2027. Injectables.
The demand for injectable drugs is rising. According to the GlobalData report Contract Injectable Packaging Trends in the Bio/Pharma Industry , more than half (55%) of FDA drug approvals in 2021 were accounted for by injectables. Several drug development trends are driving injectables demand.
As part of SMi’s leading series of drugdelivery device conferences, the 2022 event will provide insights into the rapidly accelerating market of combination product development with industry, device developer and regulatory perspectives. Uncover the key considerations to ensure optimal lifecycle management for drugdelivery devices.
The 2023 Transdermal and Microneedle DrugDelivery Conference will explore real world applications of microneedles in drugdelivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.
Deep S Bhattacharya, Senior Scientist, Drug Product Development and Design, Pfizer. Engage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drugdelivery systems. Who should Attend: Drug-delivery developers. Secondary packagers.
Driven by the increasing need for safe and efficient medical devices and drugdelivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Presently, polymers are employed in various fields, including agricultural, aircraft, automotive, consumer science, medicine, packaging, and sports.
By Sara M Keup In reviewing some new 2025 pharmacy rules/laws a couple interesting changes caught this bloggers attention: As of December 30, 2024, Missouri has rolled out new rules related to prescription drugdelivery requirements. The most common drug Californians may be looking for this winter is Paxlovid.
In its second interim staff report released January 14, 2025, the Federal Trade Commission (FTC) revealed that the top three pharma benefit managers (PBM) in the US inflated prices of specialty generic drugs over the past several years, resulting in them raking in billions of dollars in profits. What Is a PBM?
Lilly hit by staff accusations, FDA scrutiny at COVID drug factories ( Reuters ).
Pharma showers Menendez with rare, off-cycle burst of campaign cash as Democrats eye drug pricing reforms ( STAT ).
Rising wholesale drug prices really do matter to half of all commercially insured Americans ( STAT ).
In order to help circumvent these disadvantages, several drugdelivery devices, which enable patients to self-administer drugs through subcutaneous route are now being developed. Moreover, protein-based drugs are also well tolerated inside the body, thereby reducing the chances of causing any immune response in the body.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content